|
Alydar Highlights
- Pheromics™, a novel proprietary product platform of new drug candidates
with biological activity
- Preclinical proof of concept in selected disease models
- Multiple applications in diverse disease areas, addressing multi-billion dollar markets including cardiovascular, cancer,
neurological, and psychiatric diseases, and wound healing
- Poised to fill the need for new drug candidates
- Business model provides for multiple, diverse business relationships --
alliances, collaborative R&D, and licensing -- to discover, develop, and
commercialize infochemical-derived drugs
- Strong leadership with expertise in biopharmaceutical technology and
business
- Highly motivated team with cross-functional skills
- Exclusive relationships with world leaders in infochemical research
- Intellectual property position on compounds, uses, mechanisms of action,
and methods
- The only company using infochemicals as the basis for new pharmaceutical
products
|
 |
